Year: 2011
Type: article
Abstract: Oral cancer is one of the major global threats to public health. Oral cancer development is a tobacco-related multistep and multifocal process involving field cancerization and carcinogenesis. The rationale for molecular-targeted prevention of oral cancer is promising. Biomarkers of genomic instability, including aneuploidy and allelic imbalance, are able to measure the cancer risk of oral premalignancies. Understanding of the biology of oral carcinogenesis will give us important advances for detecting high-risk patients, monitoring preventive interventions, assessing cancer risk, and pharmacogenomics. In addition, novel chemopreventive agents based on molecular mechanisms and targets against oral cancers will be derived from research using appropriate animal carcinogenesis models. New approaches, such as interventions with molecular-targeted agents and agent combinations in high-risk oral individuals, are undoubtedly needed to reduce the devastating worldwide consequences of oral malignancy.
Source: Journal of Oncology
DOI: 10.1155/2011/603740
Authors: Takuji Tanaka, Rikako Ishigamori
Language: English
Subfield: General Dentistry
Field: Dentistry
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,550
Awards: G1082161905, 炎症性大腸発がんモデルマウスを用いた共役リノレン酸の発がん阻止効果に関する研究, G1510232949, G2406506678, G3865019376, G4253402111, Methylation of GST-P-positive tongue preneoplastic lesions, G5499588114, Strategy for the chemoprevention of hepatocellular carcinoma by targeting phosphorylated RXRa, G7110576571, G7715091689
OpenAlex ID: W2057970370
